跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
QiShen
首页
药物
QiShen
QiShen
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of Qishen Yiqi dripping pills for preparing medicine to inhibit degranulation of labrocyte
CN 1861113 A
申请人: TIANSHILI PHARM CO LTD
优先权: 2005
CN
2 件公开
Application of Qishen Yiqi dripping pills to prepare medicine for treating acute pancreatitis
CN 1861115 B
申请人: TIANJIN TASLY PHARMACEUTICAL
优先权: 2005
CN
Application of Qishen Yiqi dripping pills for preparing medicine for preventing and treating high-altitude oxygen deficit
CN 1861114 B
申请人: TIANJIN TASLY PHARMACEUTICAL
优先权: 2005
CN
Application of dripping pills containing astragalus mongholicus and ginseng for treating senile dementia
CN 1861111 B
申请人: TIANJIN TASLY PHARMACEUTICAL
优先权: 2005
CN
Aminoheteroaryl compounds as protein kinase inhibitors
US 8106197 B2
申请人: CUI JINGRONG JEAN
优先权: 2006
US
Pharmaceutical composition of Qishen in use for treating leucopenia, and preparation method
CN 101049344 B
申请人: JIANGSU INST OF CHINESE MEDICINES
优先权: 2007
CN
药物
反馈